Gaush Meditech Ltd (2407-HK) Stock Price & Analysis

Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People's Republic of China and internationally. The company operates through Proprietary Products, Distribution, Technical, and Others segments. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, and ophthalmic disease diagnosis and treatment equipment and related supporting consumables. The Distribution segment sells diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment, and related supporting consumables. The Technical segment provides warranty services, maintenance services, and after-sales services related consumables. The Others segment engages in the provision of equipment leasing and agent registration services; and licensing intellectual properties. The company sells its products directly and through distributors to public and private hospitals, and other customers. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.